231 related articles for article (PubMed ID: 34903587)
1. Withaferin A in the Treatment of Liver Diseases: Progress and Pharmacokinetic Insights.
Xia Y; Yan M; Wang P; Hamada K; Yan N; Hao H; Gonzalez FJ; Yan T
Drug Metab Dispos; 2022 May; 50(5):685-693. PubMed ID: 34903587
[TBL] [Abstract][Full Text] [Related]
2. Molecular targets and mechanisms of cancer prevention and treatment by withaferin a, a naturally occurring steroidal lactone.
Vyas AR; Singh SV
AAPS J; 2014 Jan; 16(1):1-10. PubMed ID: 24046237
[TBL] [Abstract][Full Text] [Related]
3. A Comprehensive Review and Perspective on Anticancer Mechanisms of Withaferin A in Breast Cancer.
Hahm ER; Kim SH; Singh KB; Singh K; Singh SV
Cancer Prev Res (Phila); 2020 Sep; 13(9):721-734. PubMed ID: 32727824
[TBL] [Abstract][Full Text] [Related]
4. Withaferin A: From Ancient Remedy to Potential Drug Candidate.
Sultana T; Okla MK; Ahmed M; Akhtar N; Al-Hashimi A; Abdelgawad H; Haq IU
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946778
[TBL] [Abstract][Full Text] [Related]
5. Determination of withaferin A and withanolide A in mice plasma using high-performance liquid chromatography-tandem mass spectrometry: application to pharmacokinetics after oral administration of Withania somnifera aqueous extract.
Patil D; Gautam M; Mishra S; Karupothula S; Gairola S; Jadhav S; Pawar S; Patwardhan B
J Pharm Biomed Anal; 2013 Jun; 80():203-12. PubMed ID: 23584079
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A.
Grover A; Shandilya A; Punetha A; Bisaria VS; Sundar D
BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S25. PubMed ID: 21143809
[TBL] [Abstract][Full Text] [Related]
7. Extraction Optimization for Phenolic- and Withanolide-Rich Fractions from
Kumar S; Singh R; Gajbhiye N; Dhanani T
J AOAC Int; 2018 Nov; 101(6):1773-1780. PubMed ID: 29945694
[No Abstract] [Full Text] [Related]
8. Withaferin A: From ayurvedic folk medicine to preclinical anti-cancer drug.
Hassannia B; Logie E; Vandenabeele P; Vanden Berghe T; Vanden Berghe W
Biochem Pharmacol; 2020 Mar; 173():113602. PubMed ID: 31404528
[TBL] [Abstract][Full Text] [Related]
9. Overview of the anticancer activity of withaferin A, an active constituent of the Indian ginseng Withania somnifera.
Sivasankarapillai VS; Madhu Kumar Nair R; Rahdar A; Bungau S; Zaha DC; Aleya L; Tit DM
Environ Sci Pollut Res Int; 2020 Jul; 27(21):26025-26035. PubMed ID: 32405942
[TBL] [Abstract][Full Text] [Related]
10. Review on anticancerous therapeutic potential of Withania somnifera (L.) Dunal.
Singh N; Yadav SS; Rao AS; Nandal A; Kumar S; Ganaie SA; Narasihman B
J Ethnopharmacol; 2021 Apr; 270():113704. PubMed ID: 33359918
[TBL] [Abstract][Full Text] [Related]
11. Withaferin A and its potential role in glioblastoma (GBM).
Dhami J; Chang E; Gambhir SS
J Neurooncol; 2017 Jan; 131(2):201-211. PubMed ID: 27837436
[TBL] [Abstract][Full Text] [Related]
12. Withaferin A Improves Nonalcoholic Steatohepatitis in Mice.
Patel DP; Yan T; Kim D; Dias HB; Krausz KW; Kimura S; Gonzalez FJ
J Pharmacol Exp Ther; 2019 Nov; 371(2):360-374. PubMed ID: 31420528
[TBL] [Abstract][Full Text] [Related]
13. Withania somnifera (L.) Dunal: Phytochemistry, structure-activity relationship, and anticancer potential.
Tewari D; Chander V; Dhyani A; Sahu S; Gupta P; Patni P; Kalick LS; Bishayee A
Phytomedicine; 2022 Apr; 98():153949. PubMed ID: 35151215
[TBL] [Abstract][Full Text] [Related]
14. Implications of Withaferin-A for triple-negative breast cancer chemoprevention.
Mallipeddi H; Thyagarajan A; Sahu RP
Biomed Pharmacother; 2021 Feb; 134():111124. PubMed ID: 33434782
[TBL] [Abstract][Full Text] [Related]
15. Withanolides from Withania somnifera Dunal: development of cellular technology and their production.
Sangwan NS; Sabir F; Mishra S; Bansal S; Sangwan RS
Recent Pat Biotechnol; 2014; 8(1):25-35. PubMed ID: 24354530
[TBL] [Abstract][Full Text] [Related]
16. Studies on oral bioavailability and first-pass metabolism of withaferin A in rats using LC-MS/MS and Q-TRAP.
Dai T; Jiang W; Guo Z; Wang Z; Huang M; Zhong G; Liang C; Pei X; Dai R
Biomed Chromatogr; 2019 Sep; 33(9):e4573. PubMed ID: 31062367
[TBL] [Abstract][Full Text] [Related]
17.
Dutta R; Khalil R; Green R; Mohapatra SS; Mohapatra S
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731424
[TBL] [Abstract][Full Text] [Related]
18. Evaluating anticancer properties of Withaferin A-a potent phytochemical.
Atteeq M
Front Pharmacol; 2022; 13():975320. PubMed ID: 36339589
[TBL] [Abstract][Full Text] [Related]
19. Standardized root extract of Withania somnifera and Withanolide A exert moderate vasorelaxant effect in the rat aortic rings by enhancing nitric oxide generation.
Pathak P; Shukla P; Kanshana JS; Jagavelu K; Sangwan NS; Dwivedi AK; Dikshit M
J Ethnopharmacol; 2021 Oct; 278():114296. PubMed ID: 34090907
[TBL] [Abstract][Full Text] [Related]
20. Withaferin A, a polyfunctional pharmacophore that includes covalent engagement of IPO5, is an inhibitor of influenza A replication.
Patouret R; Barluenga S; Winssinger N
Bioorg Med Chem; 2022 Sep; 69():116883. PubMed ID: 35772286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
